190 related articles for article (PubMed ID: 33903709)
41. Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19.
Ventero MP; Cuadrat RRC; Vidal I; Andrade BGN; Molina-Pardines C; Haro-Moreno JM; Coutinho FH; Merino E; Regitano LCA; Silveira CB; Afli H; López-Pérez M; Rodríguez JC
Front Microbiol; 2021; 12():637430. PubMed ID: 33815323
[TBL] [Abstract][Full Text] [Related]
42. Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients.
Tutuncu EE; Ozgur D; Karamese M
J Med Virol; 2021 May; 93(5):2932-2937. PubMed ID: 33501645
[TBL] [Abstract][Full Text] [Related]
43. Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.
Fan G; Qin X; Streblow DN; Hoyos CM; Hansel DE
Microbiol Spectr; 2021 Sep; 9(1):e0006221. PubMed ID: 34431689
[TBL] [Abstract][Full Text] [Related]
44. Quantitative detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.
Bustos P; Tambley C; Acevedo A; Andrade W; Leal G; Vidal D; Roldán F; Fasce R; Ramírez E
J Med Virol; 2021 Apr; 93(4):2439-2445. PubMed ID: 33368332
[TBL] [Abstract][Full Text] [Related]
45. SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment.
Marotz C; Belda-Ferre P; Ali F; Das P; Huang S; Cantrell K; Jiang L; Martino C; Diner RE; Rahman G; McDonald D; Armstrong G; Kodera S; Donato S; Ecklu-Mensah G; Gottel N; Salas Garcia MC; Chiang LY; Salido RA; Shaffer JP; Bryant MK; Sanders K; Humphrey G; Ackermann G; Haiminen N; Beck KL; Kim HC; Carrieri AP; Parida L; Vázquez-Baeza Y; Torriani FJ; Knight R; Gilbert J; Sweeney DA; Allard SM
Microbiome; 2021 Jun; 9(1):132. PubMed ID: 34103074
[TBL] [Abstract][Full Text] [Related]
46. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
Zuo T; Zhan H; Zhang F; Liu Q; Tso EYK; Lui GCY; Chen N; Li A; Lu W; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Oct; 159(4):1302-1310.e5. PubMed ID: 32598884
[TBL] [Abstract][Full Text] [Related]
47. Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights.
Nagy-Szakal D; Couto-Rodriguez M; Wells HL; Barrows JE; Debieu M; Butcher K; Chen S; Berki A; Hager C; Boorstein RJ; Taylor MK; Jonsson CB; Mason CE; O'Hara NB
Microbiol Spectr; 2021 Oct; 9(2):e0019721. PubMed ID: 34468193
[TBL] [Abstract][Full Text] [Related]
48. Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March-May 2020.
Kotwa JD; Jamal AJ; Mbareche H; Yip L; Aftanas P; Barati S; Bell NG; Bryce E; Coomes E; Crowl G; Duchaine C; Faheem A; Farooqi L; Hiebert R; Katz K; Khan S; Kozak R; Li AX; Mistry HP; Mozafarihashjin M; Nasir JA; Nirmalarajah K; Panousis EM; Paterson A; Plenderleith S; Powis J; Prost K; Schryer R; Taylor M; Veillette M; Wong T; Zoe Zhong X; McArthur AG; McGeer AJ; Mubareka S
J Infect Dis; 2022 Mar; 225(5):768-776. PubMed ID: 34850051
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of co-circulating pathogens and microbiome from COVID-19 infections.
Thissen JB; Morrison MD; Mulakken N; Nelson WC; Daum C; Messenger S; Wadford DA; Jaing C
PLoS One; 2022; 17(12):e0278543. PubMed ID: 36455065
[TBL] [Abstract][Full Text] [Related]
50. Inference of Active Viral Replication in Cases with Sustained Positive Reverse Transcription-PCR Results for SARS-CoV-2.
Rodríguez-Grande C; Adán-Jiménez J; Catalán P; Alcalá L; Estévez A; Muñoz P; Pérez-Lago L; García de Viedma D
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33239378
[TBL] [Abstract][Full Text] [Related]
51. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
52. Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses.
Ederveen THA; Ferwerda G; Ahout IM; Vissers M; de Groot R; Boekhorst J; Timmerman HM; Huynen MA; van Hijum SAFT; de Jonge MI
Microbiome; 2018 Jan; 6(1):10. PubMed ID: 29325581
[TBL] [Abstract][Full Text] [Related]
53. New insights into diversity of the upper respiratory tract microbiota and its relationship with SARS-CoV-2 viral load in the nasopharyngeal epithelial cells in patients with COVID-19.
Talaga-Ćwiertnia K; Sroka-Oleksiak A; Zapała B; Salamon D; Krawczyk A; Brzychczy-Włoch M; Gosiewski T
Pol Arch Intern Med; 2023 Aug; 133(7-8):. PubMed ID: 36826810
[TBL] [Abstract][Full Text] [Related]
54. Differential nasopharyngeal microbiota composition in children according to respiratory health status.
Henares D; Brotons P; de Sevilla MF; Fernandez-Lopez A; Hernandez-Bou S; Perez-Argüello A; Mira A; Muñoz-Almagro C; Cabrera-Rubio R
Microb Genom; 2021 Oct; 7(10):. PubMed ID: 34699345
[TBL] [Abstract][Full Text] [Related]
55. Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals.
Kumar D; Pandit R; Sharma S; Raval J; Patel Z; Joshi M; Joshi CG
Microb Pathog; 2022 Dec; 173(Pt A):105829. PubMed ID: 36252893
[TBL] [Abstract][Full Text] [Related]
56. Long-read 16S-seq reveals nasopharynx microbial dysbiosis and enrichment of
Prasad P; Mahapatra S; Mishra R; Murmu KC; Aggarwal S; Sethi M; Mohapatra P; Ghosh A; Yadav R; Dodia H; Ansari SA; De S; Singh D; Suryawanshi A; Dash R; Senapati S; Beuria TK; Chattopadhyay S; Syed GH; Swain R; Raghav SK; Parida A
Mol Omics; 2022 Jul; 18(6):490-505. PubMed ID: 35506682
[TBL] [Abstract][Full Text] [Related]
57. Liquid-based cytological and immunohistochemical study of nasopharyngeal swab from persons under investigation for SARS-CoV-2 infection.
Parada D; Peña KB; Gumà J; Guilarte C; Riu F
Histopathology; 2021 Mar; 78(4):586-592. PubMed ID: 32970870
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab.
Pagella F; Lizzio R; Ugolini S; Spinozzi G; Maiorano E; Suppressa P; Sabbà C; Matti E
Orphanet J Rare Dis; 2020 Dec; 15(1):350. PubMed ID: 33339521
[TBL] [Abstract][Full Text] [Related]
59. COVID-19 alters human microbiomes: a meta-analysis.
Reuben RC; Beugnon R; Jurburg SD
Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
[TBL] [Abstract][Full Text] [Related]
60. Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy.
Rosas-Salazar C; Shilts MH; Tovchigrechko A; Schobel S; Chappell JD; Larkin EK; Shankar J; Yooseph S; Nelson KE; Halpin RA; Moore ML; Anderson LJ; Peebles RS; Das SR; Hartert TV
J Infect Dis; 2016 Dec; 214(12):1924-1928. PubMed ID: 27923952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
